While foreign investors have been tied up with China's banks, the takeover deal of Harbin Pharmaceutical Holding Group suggests international buyout funds are at the same time looking for opportunities in different areas. An investor group led by New York-based Warburg Pincus LLC last year bought a 55 percent stake in the drug maker based in northeastern China's Heilongjiang Province last year.